Author's Reply to Perera et al.: A Commentary on "An Early Cost-Utility Model of mRNA-Based Therapies for the Treatment of Methylmalonic and Propionic Acidemia in the United Kingdom".
作者信息
Bretos-Azcona Pablo E, Wallace Matthew, Jootun Murvin, Veljanoska E, Agirrezabal Ion, Szende Agota
机构信息
Market Access & HEOR Consulting, Fortrea, London, UK.
出版信息
Clin Drug Investig. 2025 Jul;45(7):435-438. doi: 10.1007/s40261-025-01443-w. Epub 2025 May 9.
PMID:40343676
Abstract
摘要
Zotero 插件